Epsilogen Announces Completion of Oversubscribed £30.75 Million ($41.20 Million) Series B Financing
March 2, 2022
Financing led by Novartis Venture Fund and joined by new investors 3B Future Health Fund, British Patient Capital, Schroders Capital and Caribou Property alongside founding